Loading...
Loading...
Application 2113170 · Registered
| Application Number | 2113170 |
| Status | Registered |
| Owner | audentes therapeutics inc |
| Type | trade_mark |
| Filed | 2020-08-20 |
| Registered | 2021-01-07 |
Yes. OPMIRIC is a currently protected Australian trademark. It is enforceable under the Trade Marks Act 1995 (Cth) in Australia.
Key events recorded against this trademark at IP Australia, oldest first.
| Name | astellas gene therapies inc |
| Country | US |
This trademark is represented by tf9028faec74be6ec9b852b0a542e2f39, NSW, AU.
'OPMIRIC' is a protected trademark on the IP Australia register, owned by audentes therapeutics inc. The application (2113170) was filed on 20 August 2020 and registered on 7 January 2021.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
Australian trademark 2113170 for the mark 'OPMIRIC' in Class 5 is recorded on the IP Australia register as owned by audentes therapeutics inc. This covers one specific Australian trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the IP Australia records the status of Australian trademark 2113170 for the mark 'OPMIRIC' as protected.
Australian trademark 2113170 for the mark 'OPMIRIC' is registered in Class 5, which covers pharmaceuticals & medical preparations.
Australian trademark 2113170 for the mark 'OPMIRIC' was filed at the IP Australia on 20 August 2020 and registered on 7 January 2021.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence. Local copy last synchronised on 2026-05-03.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.